Earnings Data
Report Date
Nov 05, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
1.99Last Year’s EPS
2.67Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
DE:LGDN Q2 2026 Earnings Report
DE:LGDN Upcoming Earnings
Ligand Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:LGDN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:LGDN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2026 | €258.00 | €258.00 | 0.00% |
May 07, 2026 | €195.00 | €196.00 | +0.51% |
Feb 26, 2026 | €157.00 | €152.00 | -3.18% |
Nov 06, 2025 | €163.00 | €165.00 | +1.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ligand Pharma (DE:LGDN) report earnings?
Ligand Pharma (DE:LGDN) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
What is Ligand Pharma (DE:LGDN) earnings time?
Ligand Pharma (DE:LGDN) earnings time is at Nov 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ligand Pharma stock?
The P/E ratio of Ligand Pharma is N/A.
What is DE:LGDN EPS forecast?
DE:LGDN EPS forecast for the fiscal quarter 2026 (Q3) is 1.99.